PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32572550-2	2020	Sulbactam, when administered , will effectively inhibit all Extended-spectrum beta lactamases (ESBLs) of the microorganism, while cefepime will inhibit the growth of the resistant microorganisms since it will not be hydrolyzed by OXA-48.	Sulbactam	0-9	OXA-48	Klebsiella pneumoniae	230-236	
32572550-11	2020	The findings of this study displayed that cefepime + sulbactam combination had synergistic or additive effect against OXA-48-producing K. pneumoniae strains.	Sulbactam	53-62	OXA-48	Klebsiella pneumoniae	118-124	
32572550-13	2020	Further investigations may be helpful for understanding the effectiveness of cefepime + sulbactam combinations for OXA-48-positive carbapenem-resistant K. pneumoniae isolates.	Sulbactam	88-97	OXA-48	Klebsiella pneumoniae	115-121	
27125555-0	2016	LN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48.	Sulbactam	12-37	OXA-48	Klebsiella pneumoniae	80-86	
27125555-4	2016	METHODS: The OXA-48 gene was cloned and expressed in Klebsiella pneumoniae and Escherichia coli in order to obtain MICs in the presence of inhibitors (clavulanic acid, tazobactam and sulbactam) and LN-1-255.	Sulbactam	183-192	OXA-48	Klebsiella pneumoniae	13-19